Harry Kovelman
Known title: Chief Medical OfficerCIK: 0001853204
Harry Kovelman's purchase track record
Harry Kovelman has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/29/2023 | MYO | $5K | +304.8% | +289.6% | +12.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| MYO | ▼ Sell | Open Market | 15,488 | $20K | 9/11/2026 | View on chart |
| MYO | ▼ Sell | Open Market | 17,250 | $30K | 8/20/2026 | View on chart |
| MYO | ▲ Buy | Grant | 55,149 | $0 | 8/7/2026 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 22,457 | $32K | 8/7/2026 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 10,442 | $13K | 6/12/2026 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 7,635 | $10K | 6/8/2026 | View on chart |
| MYO | ▼ Sell | Open Market | 11,536 | $12K | 5/28/2026 | View on chart |
| MYO | ▼ Sell | Open Market | 20,464 | $21K | 5/27/2026 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 13,054 | $29K | 6/30/2025 | View on chart |
| MYO | ▲ Buy | Grant | 62,938 | $0 | 6/11/2025 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 5,743 | $17K | 6/6/2025 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 1,496 | $8K | 3/13/2025 | View on chart |
| MYO | ▼ Sell | Open Market | 30,000 | $165K | 3/12/2025 | View on chart |
| MYO | ▲ Buy | Grant | 3,553 | $0 | 3/11/2025 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 121 | $448 | 11/4/2024 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 121 | $467 | 10/3/2024 | View on chart |
| MYO | ▼ Sell | Open Market | 6,700 | $25K | 9/5/2024 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 139 | $541 | 9/4/2024 | View on chart |
| MYO | ▼ Sell | Open Market | 2,029 | $8K | 9/3/2024 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 128 | $507 | 8/5/2024 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 121 | $345 | 7/3/2024 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 12,868 | $39K | 7/1/2024 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 5,347 | $18K | 6/10/2024 | View on chart |
| MYO | ▲ Buy | Option Exercise | 1,235 | $0 | 6/9/2024 | View on chart |
| MYO | ▲ Buy | Grant | 53,000 | $0 | 6/5/2024 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 121 | $421 | 6/3/2024 | View on chart |
| MYO | ▼ Sell | Open Market | 35,426 | $131K | 5/15/2024 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 146 | $561 | 5/3/2024 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 146 | $434 | 4/3/2024 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 6,590 | $23K | 3/11/2024 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 147 | $570 | 3/5/2024 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 146 | $469 | 2/5/2024 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 145 | $680 | 1/3/2024 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 99 | $398 | 12/5/2023 | View on chart |
| MYO | ▼ Sell | Open Market | 8,333 | — | 12/1/2023 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 121 | $171 | 11/6/2023 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 123 | $135 | 10/3/2023 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 125 | $109 | 9/5/2023 | View on chart |
| MYO | ▲ Buy | Open Market | 8,333 | $5K | 8/29/2023 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 125 | $89 | 8/3/2023 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 109 | $65 | 7/5/2023 | View on chart |
| MYO | ▲ Buy | Grant | 80,000 | $0 | 6/28/2023 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 499 | $230 | 6/9/2023 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 5,105 | $2K | 6/8/2023 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 125 | $69 | 6/6/2023 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 131 | $72 | 5/3/2023 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 129 | $94 | 4/3/2023 | View on chart |
| MYO | ▲ Buy | Grant | 17,000 | $0 | 3/8/2023 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 130 | $81 | 3/3/2023 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 132 | $65 | 2/3/2023 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 139 | $68 | 1/4/2023 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 126 | $83 | 12/5/2022 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 125 | $171 | 11/3/2022 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 128 | $201 | 10/3/2022 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 128 | $225 | 9/6/2022 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 118 | $226 | 8/3/2022 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 127 | $208 | 7/5/2022 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 484 | $886 | 6/13/2022 | View on chart |
| MYO | ▲ Buy | Grant | 28,000 | $0 | 6/8/2022 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 138 | $319 | 6/3/2022 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 2,849 | $6K | 5/24/2022 | View on chart |
| MYO | ▲ Buy | Grant | 6,987 | $0 | 5/20/2022 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 134 | $406 | 5/3/2022 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 134 | $537 | 4/4/2022 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 131 | $946 | 3/7/2022 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 132 | $1K | 2/3/2022 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 125 | $903 | 1/3/2022 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 128 | $992 | 12/3/2021 | View on chart |
| MYO | ▼ Sell | Tax Withholding | 1,625 | $17K | 11/3/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
MYO appoints Mary-Katherine McClure as Chief Commercial Officer
Myomo announced that Mary‑Katherine McClure has been named chief commercial officer. McClure will lead the company’s sales and marketing efforts and oversee commercial strategy. The addition of an experienced executive comes as the stock is trading near a long‑standing support level.
MYO appoints Mary-Katherine McClure as Chief Commercial Officer. Myomo announced that Mary‑Katherine McClure has been named chief commercial officer. McClure will lead the company’s sales and marketing efforts and oversee commercial strategy. The addition of an experienced executive comes as the stock is trading near a long‑standing support level.